190 related articles for article (PubMed ID: 29301833)
1. Establishing a Preclinical Multidisciplinary Board for Brain Tumors.
Nimmervoll BV; Boulos N; Bianski B; Dapper J; DeCuypere M; Shelat A; Terranova S; Terhune HE; Gajjar A; Patel YT; Freeman BB; Onar-Thomas A; Stewart CF; Roussel MF; Guy RK; Merchant TE; Calabrese C; Wright KD; Gilbertson RJ
Clin Cancer Res; 2018 Apr; 24(7):1654-1666. PubMed ID: 29301833
[No Abstract] [Full Text] [Related]
2. Preclinical studies of 5-fluoro-2'-deoxycytidine and tetrahydrouridine in pediatric brain tumors.
Morfouace M; Nimmervoll B; Boulos N; Patel YT; Shelat A; Freeman BB; Robinson GW; Wright K; Gajjar A; Stewart CF; Gilbertson RJ; Roussel MF
J Neurooncol; 2016 Jan; 126(2):225-34. PubMed ID: 26518542
[TBL] [Abstract][Full Text] [Related]
3. Formulation of a triple combination gemcitabine plus romidepsin + cisplatin regimen to efficaciously and safely control triple-negative breast cancer tumor development.
Pattarawat P; Wallace S; Pfisterer B; Odoi A; Wang HR
Cancer Chemother Pharmacol; 2020 Jan; 85(1):141-152. PubMed ID: 31865420
[TBL] [Abstract][Full Text] [Related]
4. Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer.
Burkhart C; Fleyshman D; Kohrn R; Commane M; Garrigan J; Kurbatov V; Toshkov I; Ramachandran R; Martello L; Gurova KV
Oncotarget; 2014 Nov; 5(22):11038-53. PubMed ID: 25402820
[TBL] [Abstract][Full Text] [Related]
5. A combination of DR5 agonistic monoclonal antibody with gemcitabine targets pancreatic cancer stem cells and results in long-term disease control in human pancreatic cancer model.
Rajeshkumar NV; Rasheed ZA; García-García E; López-Ríos F; Fujiwara K; Matsui WH; Hidalgo M
Mol Cancer Ther; 2010 Sep; 9(9):2582-92. PubMed ID: 20660600
[TBL] [Abstract][Full Text] [Related]
6. Synergistic activity of troxacitabine (Troxatyl) and gemcitabine in pancreatic cancer.
Damaraju VL; Bouffard DY; Wong CK; Clarke ML; Mackey JR; Leblond L; Cass CE; Grey M; Gourdeau H
BMC Cancer; 2007 Jul; 7():121. PubMed ID: 17608948
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
Abdel-Rahman O; Elsayed Z; Elhalawani H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
[TBL] [Abstract][Full Text] [Related]
8. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
9. Synergistic antitumor activity of ZD6474, an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, with gemcitabine and ionizing radiation against pancreatic cancer.
Bianco C; Giovannetti E; Ciardiello F; Mey V; Nannizzi S; Tortora G; Troiani T; Pasqualetti F; Eckhardt G; de Liguoro M; Ricciardi S; Del Tacca M; Raben D; Cionini L; Danesi R
Clin Cancer Res; 2006 Dec; 12(23):7099-107. PubMed ID: 17145834
[TBL] [Abstract][Full Text] [Related]
10. Anti-mesothelin immunotoxin SS1P in combination with gemcitabine results in increased activity against mesothelin-expressing tumor xenografts.
Hassan R; Broaddus VC; Wilson S; Liewehr DJ; Zhang J
Clin Cancer Res; 2007 Dec; 13(23):7166-71. PubMed ID: 18056197
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer.
Espey MG; Chen P; Chalmers B; Drisko J; Sun AY; Levine M; Chen Q
Free Radic Biol Med; 2011 Jun; 50(11):1610-9. PubMed ID: 21402145
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human HT-29 colon carcinoma and human CaKi1 renal cell carcinoma xenografts.
Teicher BA; Menon K; Alvarez E; Galbreath E; Shih C; Faul MM
Anticancer Res; 2001; 21(5):3175-84. PubMed ID: 11848470
[TBL] [Abstract][Full Text] [Related]
13. Modeling targeted inhibition of MEK and PI3 kinase in human pancreatic cancer.
Junttila MR; Devasthali V; Cheng JH; Castillo J; Metcalfe C; Clermont AC; Otter DD; Chan E; Bou-Reslan H; Cao T; Forrest W; Nannini MA; French D; Carano R; Merchant M; Hoeflich KP; Singh M
Mol Cancer Ther; 2015 Jan; 14(1):40-7. PubMed ID: 25376606
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic Acid-Modified Micelles Encapsulating Gem-C
Liu X; Li W; Chen T; Yang Q; Huang T; Fu Y; Gong T; Zhang Z
Mol Pharm; 2018 Mar; 15(3):1203-1214. PubMed ID: 29397747
[TBL] [Abstract][Full Text] [Related]
15. Preclinical studies of gemcitabine and trastuzumab in breast and lung cancer cell lines.
Hirsch FR; Helfrich B; Franklin WA; Varella-Garcia M; Chan DC; Bunn PA
Clin Breast Cancer; 2002 May; 3 Suppl 1():12-6. PubMed ID: 12057039
[TBL] [Abstract][Full Text] [Related]
16. The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin's lymphoma.
Toner LE; Vrhovac R; Smith EA; Gardner J; Heaney M; Gonen M; Teruya-Feldstein J; Sirotnak F; O'Connor OA
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):924-32. PubMed ID: 16467107
[TBL] [Abstract][Full Text] [Related]
17. Intralesional injection of rose bengal augments the efficacy of gemcitabine chemotherapy against pancreatic tumors.
Innamarato P; Morse J; Mackay A; Asby S; Beatty M; Blauvelt J; Kidd S; Mullinax JE; Sarnaik AA; Pilon-Thomas S
BMC Cancer; 2021 Jun; 21(1):756. PubMed ID: 34187428
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic activity of gemcitabine in intracranial tumors].
Stukov AN; Filatova LV; Latipova DKh; Bespalov VG; Belyaeva OA; Kireeva GS; Vasilieva IN; Alexandrov VA; Maidin MA; Semenov AL; Vershinina SF; Markochev AB; Abduloeva NKh; Chubenko VA; Semiglazova TY
Vopr Onkol; 2015; 61(2):274-9. PubMed ID: 26087611
[TBL] [Abstract][Full Text] [Related]
19. Brain metastases of epithelial ovarian carcinoma responding to cisplatin and gemcitabine combination chemotherapy: a case report and review of the literature.
Melichar B; Urminská H; Kohlová T; Nová M; Cesák T
Gynecol Oncol; 2004 Aug; 94(2):267-76. PubMed ID: 15297161
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy and radiotherapy for advanced pancreatic cancer.
Chin V; Nagrial A; Sjoquist K; O'Connor CA; Chantrill L; Biankin AV; Scholten RJ; Yip D
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011044. PubMed ID: 29557103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
